Sponsor:
C17 Council
Code:
NCT06942039
Conditions
CNS Embryonal Tumor
CNS, Medulloblastoma
Atypical Teratoid Rhabdoid Tumor
Medulloblastoma, Childhood
Medulloblastoma, Group 3
Eligibility Criteria
Sex: All
Age: 0 - 6
Healthy Volunteers: Not accepted
Interventions
Cytarabine IT
hydrocortisone
Cisplatin
Vincristine
Etoposide
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-25. This information was provided to ClinicalTrials.gov by C17 Council on 2025-12-18.